MYCN-amplification leads to upregulation of hypoxia-inducible factor-1α (HIF-1α), a transcription factor that in concert with MYCN, enhances the expression of glycolytic genes and drives neuroblastoma tumour progression [43]. The gene discussed is MYCN; the disease is neuroblastoma.